A Mass General research team is investigating if boosting a specific brain activity during sleep can help treat learning and memory deficits in schizophrenia patients.
Blog
When it comes to assessing the damage caused by natural disasters, experts often think in terms of primary and secondary effects. A primary effect of a flood, for example, would include the damage to homes and buildings caused by the rushing waters, while a secondary effect would be power outages resulting from downed trees andRead more
A new research study from Rudolph Tanzi, PhD, and Robert Moir, PhD, researchers in the Department of Neurology at Massachusetts General Hospital, has uncovered a Jekyll and Hyde role for a naturally occurring protein in the brain most commonly associated with Alzheimer’s disease (AD). In conjunction with new findings from another research team at Icahn School ofRead more
Anxious people often don’t sleep well and poor sleep is a symptom of many psychiatric disorders, including anxiety.
From the Wall Street Journal to local TedTalks, Massachusetts General Hospital researchers are finding new outlets for sharing their science with the public. Check out just a few recent videos highlighting investigators from Mass General: Twenty Americans die every day waiting for transplants. Now researcher Harald C. Ott, MD, from the Department of Surgery thinksRead more
Gunes Sevinc, PhD Gunes Sevinc, PhD, is a postdoctoral research fellow in the lab of Sara Lazar, PhD, in the Department of Psychiatry at Massachusetts General Hospital. Her poster recently won an award at Mass General’s Research Fellow Poster Celebration. Continue reading to hear Dr. Sevinc explain her research: Being able to regulate one’s emotionsRead more
Amanda Furness, PhD Amanda Furness, PhD, is a postdoctoral research fellow in the Center for Genomic Medicine at Massachusetts General Hospital. Her poster, Therapeutic insight into Mucolipidosis IV via in vitro glia models, recently won an award at Mass General’s Research Fellow Poster Celebration. We asked Dr. Furness about her research: What problem(s) are youRead more
Researchers at Massachusetts General Hospital have developed a new technique for imaging the brains of patients with amyotrophic lateral sclerosis (ALS) that could vastly reduce the cost and time needed for new clinical trials—while also improving the accuracy of test results.
James Berry, a researcher in the Neurological Clinical Research Institute at Massachusetts General Hospital, is working to build tools and identify biomarkers to improve clinical trial methodology. His goal is to speed up the process of identifying the next drug that will slow, reverse or even prevent ALS in the future
Katharine Nicholson, MD Hereditary forms of amyotrophic lateral sclerosis (ALS) may only account for 10 percent of all ALS cases, but the insights that researchers gain from studying this small population may be the key to unlocking new treatments for this devastating disease. That’s the hope of Katharine Nicholson, MD, a physician-investigator at the NeurologicalRead more